Senior Director, Corporate Communication
Phone: +45 3083 2851
We are always available to take your enquiries. Please send an email or give us a call. For general press enquiries, please call +45 3643 4000.
Please note that the contacts listed to the right are for journalists or people with media related questions. If you are not a journalist, please visit the contact page and consult the appropriate Lundbeck contact.
We are a global pharmaceutical company highly committed to improving the quality of life for people living with brain diseases. For this purpose, we are engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. Our pharmaceuticals are targeted at disorders such as depression, schizophrenia, Alzheimer's and Parkinson's diseases.
Focus on R&D is the most important pillar in Lundbeck’s ambition to improve treatment for people living with brain diseases. We are specialists in our area and our research center is placed in Denmark. Approximately 800 employees work in our R&D units. We cooperate closely with strategic partners all over the world, ensuring the best possible foundation for innovation and the development of new treatment solutions.
In total, Lundbeck, headquartered in Copenhagen, Denmark, employs approximately 5,000 people all over the world, 1,900 of which work in Denmark. Lundbeck has employees in more than 50 countries.